Sanofi SA (ADR) (NYSE:SNY) belongs to Healthcare sector. Its net profit margin is 12.30% and weekly performance is 8.20%. On last trading day company shares ended up $52.10. Sanofi SA (ADR) (NYSE:SNY) distance from 50-day simple moving average (SMA50) is 4.30%. On July 8, Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) and Sanofi SA (ADR) (NYSE:SNY) announced that the Phase 3 ODYSSEY JAPAN trial of the investigational therapy Praluent® (alirocumab) Injection met its primary endpoint. At week 24, patients in the Praluent group experienced an average 64 percent greater reduction from baseline in their bad cholesterol, known as low-density lipoprotein cholesterol (LDL-C), when added to current standard of care including statins, compared to standard of care alone (p less than 0.0001).
Momenta Pharmaceuticals Inc. (NASDAQ:MNTA) shares remains unchanged in last trading session and ended the day at $21.76. MNTA return on assets is -36.40%. Momenta Pharmaceuticals Inc. (NASDAQ:MNTA) quarterly performance is 33.17%.
On 13 July, Polaris Industries Inc. (NYSE:PII) shares moved up 0.77% and was closed at $152.21. PII EPS growth in last 5 year was 34.20%. Polaris Industries Inc. (NYSE:PII) year to date (YTD) performance is 1.35%. Recreational vehicle maker Polaris Industries Inc. (NYSE:PII) said Monday that Michael Malone has declared his intention to retire as Vice President, Finance and Chief Financial Officer effective August 3, but has agreed to stay on into early 2016 to assume the newly-formed role of Executive Vice President, Polaris Financial Services.
Cardiovascular Systems Inc. (NASDAQ:CSII) ended the last trading day at $30.81. Company weekly volatility is calculated as 5.10% and price to cash ratio as 10.45. Cardiovascular Systems Inc. (NASDAQ:CSII) showed a weekly performance of 14.32%. Cardiovascular Systems Inc. (NASDAQ:CSII), announced that it has completed enrollment for its Coronary Orbital Atherectomy System Trial (COAST) study. Taking place in both Japan and the United States, the study is designed to assess the safety and efficacy, as well as economic outcomes, of CSI’s new micro crown Orbital Atherectomy System (OAS) in treating severely calcified coronary lesions in patients suffering from Coronary Artery Disease (CAD). As designed, a total of 100 patients were enrolled in the study.
Assurant Inc. (NYSE:AIZ) shares moved up 1.52% in last trading session and ended the day at $71.27. AIZ return on assets is 1.20%. Assurant Inc. (NYSE:AIZ) quarterly performance is 15.10%. Assurant Inc. (NYSE:AIZ), has finalized its $1.3 billion 2015 Property Catastrophe Reinsurance Program, which reduces the Company’s financial exposure and ensures its ability to safeguard homeowners and renters suffering catastrophic losses caused by severe weather events.